300
Participants
Start Date
March 1, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Observation
The study was observational and did not involve any intervention.
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian
Suzhou Jiulong Hospital, Suzhou
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Northern Jiangsu People's Hospital, Yangzhou
Lead Sponsor
Nanjing Broad Biopharmaceutical Ltd.
NETWORK